Skip to main content

Table 2 Results of posterior subtenon methylprednisolone acetate injection for refractory diabetic macular edema in two different groups.

From: The effect of posterior subtenon methylprednisolone acetate in the refractory diabetic macular edema: a prospective nonrandomized interventional case series

 

Mean ± SD

 
 

Before injection

After injection

P-Value*

  

1 week

1 month

3 months

 

Group 1(n = 30)

VA (logMAR)

0.6 ± 0.27

0.3 ± 0.20

0.3 ± 0.21

0.3 ± 0.22

0.0001

CMT (μm)

367 ± 65

248 ± 44

222 ± 35

226 ± 40

0.0001

Group 2(n = 22)

VA (logMAR)

1.1 ± 0.27

1.0 ± 0.27

1.0 ± 0.25

1.0 ± 0.25

0.32

CMT (μm)

417 ± 86

286 ± 76

241 ± 43

238 ± 39

0.0001

  1. CMT = central macular thickness; Group 1 = eyes having refractory diffuse CSME with extrafoveal hard exudates; Group 2 = eyes having refractory diffuse CSME with subfoveal hard exudates; logMAR = logarithm of minimal angle of resolution; VA = visual acuity; *p < 0.05 is statistically significant
Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us